APA (7th ed.) Citation

H, B., R, S., RH, A., A, M., AA, A., & AM, A. R. (2024). Untargeted metabolomics reveals the impact of Liraglutide treatment on metabolome profiling and metabolic pathways in type-2 diabetes mellitus. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 32(11), . https://doi.org/10.1016/j.jsps.2024.102172

Chicago Style (17th ed.) Citation

H, Benabdelkamel, Sebaa R, AlMalki RH, Masood A, Alfadda AA, and Abdel Rahman AM. "Untargeted Metabolomics Reveals the Impact of Liraglutide Treatment on Metabolome Profiling and Metabolic Pathways in Type-2 Diabetes Mellitus." Saudi Pharmaceutical Journal : SPJ : The Official Publication of the Saudi Pharmaceutical Society 32, no. 11 (2024). https://doi.org/10.1016/j.jsps.2024.102172.

MLA (9th ed.) Citation

H, Benabdelkamel, et al. "Untargeted Metabolomics Reveals the Impact of Liraglutide Treatment on Metabolome Profiling and Metabolic Pathways in Type-2 Diabetes Mellitus." Saudi Pharmaceutical Journal : SPJ : The Official Publication of the Saudi Pharmaceutical Society, vol. 32, no. 11, 2024, https://doi.org/10.1016/j.jsps.2024.102172.